02617 Overview

TENCENT's Trading Activity: TENCENT (00700.HK) saw a significant Southbound Trading net inflow of HKD2.3 billion, with a closing increase of 3.386% and a short selling ratio of 22.518%.

BABA-W and Other Stocks' Outflows: BABA-W (09988.HK), SMIC (00981.HK), and YOFC (06869.HK) experienced substantial Southbound Trading net outflows totaling HKD1.56 billion, with BABA-W showing a short selling ratio of 18.050%.

Market Overview: Overall, Southbound Trading net outflow was zero, accounting for 40.48% of the total transaction amount of HKD118.5 billion, indicating a balanced trading environment.

Analyst Insights: JPMorgan maintained a neutral stance on XIAOMI-W (01810.HK) but reduced its target price due to anticipated margin pressures, reflecting cautious sentiment in the market.

Stock Performance Overview: Various Hong Kong stocks showed mixed performance, with ZIJIN GOLD INTL and MINIMAX-WP experiencing significant gains, while others like GUMING and CHERY AUTO faced declines.

Short Selling Data: Short selling activity varied across stocks, with FWD showing a high short selling ratio of 16.999%, while NANSHAN AL INTL had a notably low ratio of 0.135%.

Market Capitalization Insights: The market capitalization at the end of the lock-up periods for these stocks ranges from 21.4 billion to 406.6 billion, indicating varying levels of investor interest and company valuations.

Future Lock-up Dates: Key lock-up expiration dates for these stocks are set between early 2026 and late 2026, which may impact trading strategies and stock performance as these dates approach.

US Stock Market Performance: US stocks fell 398 points (0.8%) following JPMorgan's earnings report, while chip stocks saw increased interest.

Hong Kong Market Opening: The Hong Kong bourse opened higher, with the HSI up 123 points (0.5%) and notable gains in tech stocks like BABA-W and TENCENT.

Inflation Rate in China: China's inflation rate for December was reported at 0.8%, slightly above the previous 0.7% but below the forecast of 0.9%.

Pharmaceutical Sector Activity: Several pharmaceutical stocks, including HANSOH PHARMA and BEONE MEDICINES, opened higher, while PHARMARON anticipated a decrease in full-year profit but still saw a slight increase in stock price.

Share Placement Announcement: TRANSTHERA-B (02617.HK) announced the placement of 2.1 million shares at HKD92.85 per share, representing a 17.98% discount from the previous closing price of HKD113.2.

Funding Purpose: The placement is expected to raise approximately HKD190 million, with around 60% allocated for the ongoing clinical trial of Tinengotinib for cholangiocarcinoma treatment and further research and development of the product.

Stock Performance: TRANSTHERA-B (02617.HK) opened 1.7% lower and experienced a significant decline, dropping as much as 18.8% to a low of HKD137 before recovering slightly to HKD140, down 17.01%.

Trading Volume: The trading volume reached 2.008 million shares, with a total value of HKD294 million.

Initial Listing: The company was listed on June 23 at an initial price of HKD13.15 per share.

Lock-up Period: The six-month lock-up period for cornerstone investors ends today, which may influence stock trading dynamics.

Market Performance: The Hang Seng Index (HSI) rose by 233 points (0.9%) to close at 25,468, with significant gains also seen in the HSTI and HSCEI, which increased by 55 points (1.0%) and 85 points (1.0%) respectively, and market turnover reached $183.14 billion.

Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, Alibaba, and Xiaomi saw positive movements, with Meituan closing up 1.8% at $101.3 and Tencent up 1.4% at $605, amidst notable short selling activity.

HSI & HSCEI Constituents on Move: China Life and Li Ning experienced substantial gains, with China Life rising 4.3% to $28.56 and Li Ning also up 4.3% to $19.07, reflecting strong investor interest.

Notable Stock Surge: Transthera-B saw a remarkable increase of 17.4%, closing at $171.3, indicating a significant upward trend in its stock performance.